clopidogrel has been researched along with Brain Edema in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allouche, N; Araújo, JL; Bachega, JFR; da Silva Santos, AL; da Silva, FI; de Oliveira Schinoff, B; Derbali, F; Ghazouani, L; Hajji, R; Mnafgui, K; Tlili, A | 1 |
| Guo, D; Han, XW; Jia, YX; Li, TF; Ma, J; Shui, SF; Yan, L; Yuan, HF | 1 |
| Baumgartner, RW; Bogousslavsky, J; Georgiadis, D; Michel, P | 1 |
| Hong, KW; Lee, JH; Lee, WS; Park, SY | 1 |
1 review(s) available for clopidogrel and Brain Edema
| Article | Year |
|---|---|
[Treatment of acute stroke -- an overview].
Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Aspirin; Brain Edema; Case-Control Studies; Cerebral Infarction; Clinical Trials, Phase IV as Topic; Clopidogrel; Contraindications; Double-Blind Method; Fibrinolytic Agents; Heparin; Humans; Hypertension; Immunoglobulin Fab Fragments; Intracranial Pressure; Intubation, Intratracheal; Ischemic Attack, Transient; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Placebos; Plasminogen Activators; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Randomized Controlled Trials as Topic; Respiration, Artificial; Stroke; Thrombolytic Therapy; Ticlopidine; Time Factors; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Ultrasonography | 2003 |
3 other study(ies) available for clopidogrel and Brain Edema
| Article | Year |
|---|---|
Oleuropein Protects Against Cerebral Ischemia Injury in Rats: Molecular Docking, Biochemical and Histological Findings.
Topics: Acetylcholinesterase; Animals; Brain; Brain Edema; Clopidogrel; Free Radical Scavengers; Humans; Hyponatremia; Infarction, Middle Cerebral Artery; Iridoid Glucosides; Male; Molecular Docking Simulation; Neuroprotective Agents; Oxidative Stress; Peptidyl-Dipeptidase A; Protein Binding; Protein Disulfide-Isomerases; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2021 |
Chrysin ameliorates cerebral ischemia/reperfusion (I/R) injury in rats by regulating the PI3K/Akt/mTOR pathway.
Topics: Animals; Apoptosis; Brain Edema; Cell Line; Clopidogrel; Drug Evaluation, Preclinical; Flavonoids; Infarction, Middle Cerebral Artery; Inflammation; Interleukin-1beta; Interleukin-6; Male; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Superoxide Dismutase-1; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2019 |
Lack of antiapoptotic effects of antiplatelet drug, aspirin and clopidogrel, and antioxidant, MCI-186, against focal ischemic brain damage in rats.
Topics: Animals; Antioxidants; Antipyrine; Aspirin; bcl-2-Associated X Protein; Blotting, Western; Brain Edema; Brain Ischemia; Cerebral Infarction; Clopidogrel; Cyclic AMP Response Element-Binding Protein; Disability Evaluation; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Administration Routes; Edaravone; Functional Laterality; Gene Expression Regulation; Hypoxia, Brain; Male; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; Ticlopidine; Tumor Suppressor Proteins | 2005 |